| Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160) |
|---|
| 03/06/2002 | EP1183230A1 Valency platform molecules comprising aminooxy groups |
| 03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
| 03/06/2002 | EP1183019A2 Ace-2 inhibiting compounds and methods of use thereof |
| 03/06/2002 | EP0695295B1 3-(hetero)aryl carboxylic acid derivatives, methods of preparing them and intermediates used in their preparation |
| 03/06/2002 | CN1080251C Dihalopropene compound, insecticide/acaricide containing said dihalopropene compound as active ingredient and intermediate compound for use inproduct of said dihalopropene compounds |
| 03/05/2002 | US6353023 Aromatic compounds with amide groups |
| 03/05/2002 | US6353017 Inhibitors of cathespins using dipeptide nitriles as antiinflammatory agents and antiarthritic agents |
| 03/05/2002 | US6353011 Drugs for endocrines and cardiovascular disorders |
| 03/05/2002 | US6352839 Preparing virginiamycins from an engineered microorganisms, having the ability to prevent biosynthesis of the precursor antibiotic; the microorganism is cultured in the presence of a second precursor and the streptogramin analog is recovered |
| 03/05/2002 | CA2050465C Cyclohexenol derivatives |
| 02/28/2002 | WO2002016316A1 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE |
| 02/28/2002 | WO2002016311A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 02/28/2002 | WO2001076390A3 Flavouring a foodstuff with compounds containing a sulfur atom linked to two specific atoms or groups |
| 02/28/2002 | WO2001068593A3 Amino acid derivatives as hiv aspartyl protease inhibitors |
| 02/28/2002 | US20020026082 Preparing beta-carotene; retinyl sulfide, synthesized by coupling of a diallylic sulfide with the corresponding Wittig salt. |
| 02/28/2002 | US20020026076 Heating the acylamino acid to a temperature in the range from 110 degrees C. to 220 degrees C. and hydrolyzing |
| 02/28/2002 | US20020026060 RAR selective retinoid agonists |
| 02/28/2002 | US20020025947 Serine protease inhibitor |
| 02/28/2002 | DE10136751A1 Novel tetra- and penta-nuclear compounds with a phenylene group linked via a difluoromethylene ether group are useful in displays for out-of-doors, automobile or avionic applications |
| 02/28/2002 | CA2420289A1 10-aryl-11-hbenzo [b]fluorene derivatives and analogs for medicinal use |
| 02/27/2002 | EP1181269A1 Cell proliferation inhibitors |
| 02/27/2002 | EP1181267A1 Halogen compounds |
| 02/27/2002 | CN1337953A New thryoid receptor ligands and process II |
| 02/27/2002 | CN1337947A Acetylenic sulfonamide thiol TACE inhibitors |
| 02/27/2002 | CN1337946A S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 02/27/2002 | CN1337945A Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 02/27/2002 | CN1337394A Comprehensive cystine mother liquor utilizing process of producing single amino acid and eliminating pollution |
| 02/26/2002 | US6350892 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/21/2002 | WO2002014265A1 Novel 3-substituted urea derivatives and medicinal use thereof |
| 02/21/2002 | WO2002014261A2 4-substituted d-glutamic acid derivatives for use as antibiotic |
| 02/21/2002 | WO2002014260A1 Hydrolysis of acylamino acids |
| 02/21/2002 | US20020022744 Forming mixture of solution of cystine in aqueous sulfuric acid and of an aqueous solution of a base by simultaneous metering cystine solution and aqueous base solution into a mixing container; precipitating solid crystals of cystine |
| 02/21/2002 | US20020022643 1,1- and 1,2-disubstituted cyclopropane compounds |
| 02/21/2002 | DE10039389A1 Carbenoide enthaltende Rutheniumkomplexe Carbenoids containing ruthenium |
| 02/21/2002 | DE10039268A1 Hydrolyse von Acylaminosäuren Hydrolysis of acyl amino acids |
| 02/21/2002 | DE10038038A1 Preparation of R- or S-lipoic acid via R- or S-dihydrolipoic acid useful in the pharmaceutical and food industries involves e.g. reaction of 6,8-bis(sulfonyloxy)-octanoate with sodium sulfide and sulfur and treatment with complex hydride |
| 02/20/2002 | EP1180024A1 Z-styryl sulfone anticancer agents |
| 02/20/2002 | CN1336914A Process for producing 2-hydroxy-4-methyl-thiobutanoic acid |
| 02/20/2002 | CN1336912A Novel propargylether derivatives |
| 02/20/2002 | CN1336367A Mercaptoone and mercaptol, and prepn. process therefor |
| 02/14/2002 | WO2002012224A2 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | WO2002012166A2 Triamine derivative melanocortin receptor ligands and methods of using same |
| 02/14/2002 | WO2001074318A3 Method and agents on the basis of 2-mercaptopropionic acid amides for durable hair forming and a method for producing same |
| 02/14/2002 | WO2001070671A3 Insecticidal anthranilamides |
| 02/14/2002 | US20020019563 A S-(2-(1-iminoethyl)amino)ethyl)-2-methyl-L-cysteine |
| 02/14/2002 | US20020019543 Thiol derivative, metallo-beta-lactamase inhibitors |
| 02/14/2002 | US20020019442 Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications |
| 02/14/2002 | US20020019430 Nervous system and psychological disorders |
| 02/14/2002 | CA2419036A1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | CA2419027A1 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/13/2002 | EP1178959A1 Alpha-amino-beta-sulfonyl hydroxamic acid compounds |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | CN1079095C Process for producing D.L-methionine or salt thereof |
| 02/12/2002 | CA2030338C Reducing composition for permanent hair deformation comprising as a reducing agent an amino mercaptoalkylamide or one of its salts and their useuse in permanent hair deformation process |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002009651A2 Fatty acid synthase inhibitors |
| 02/07/2002 | WO2001000566A3 Substituted phenoxyacetic acids |
| 02/07/2002 | US20020016510 In the presence of acid catalyst and of basic catalyst; provides clear, pale-coloured products; one step process |
| 02/07/2002 | US20020016491 Method for improving the selectivity of 1,3-cyclohexanedione herbicide |
| 02/07/2002 | US20020016461 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
| 02/07/2002 | US20020016364 Certain ethers of probucol, and their pharmaceutically acceptable salts or prodrugs, are useful for increasing circulating high density lipoprotein cholestrol |
| 02/07/2002 | US20020016361 Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
| 02/07/2002 | US20020016320 Inhibiting beta-secretase enzyme activity and A beta peptide production. |
| 02/07/2002 | US20020016311 Nitrate esters and their use for neurological conditions |
| 02/07/2002 | US20020016300 Treating inflammatory disorders, cardiovascular diseases, occular diseases, autoimmune diseases, neurological disorders, and cancer. The compounds also can be used to treat hyperlipidemia and/or hypercholesterolemia. |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/06/2002 | EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | EP1177182A1 Novel photoinitiators and their applications |
| 02/06/2002 | EP1177169A1 6- [(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 02/06/2002 | EP1003709B1 Fungicidal compounds having a fluorovinyloxyphenyl moiety and process for the preparation thereof |
| 02/06/2002 | EP0891325B1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
| 02/06/2002 | EP0790824B1 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same, and use thereof for treating insulin resistance |
| 02/06/2002 | EP0729354B1 Farnesyl derivatives and pharmaceutical compositions containing them |
| 02/06/2002 | CN1334800A 3,4,5-trisubstd. aryl nitrone compounds and pharmaceutical compositions contg. same |
| 02/06/2002 | CN1334726A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists |
| 02/06/2002 | CN1078888C 7-substd benzothiadiazole derivs as plant immunizing agent and preparing method therefor |
| 02/06/2002 | CN1078887C Sulfur-contg. di-tert-bytylphenol compounds useful as anti-inflammatory agents |
| 02/05/2002 | US6344561 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 02/05/2002 | US6344558 Analgesics |
| 02/05/2002 | US6344483 Halogenated amidino amino acid deviratives useful as nitric oxide synthase inhibitors |
| 02/05/2002 | US6344457 Rheumatoid arthritis, osteoarthritis, osteoporosis, corneal ulceration, periodontitis, gingivitis or tumorous invasion and metastatic proliferation, atherosclerosis, aids, chronic inflammatory diseases of the intestine |
| 02/05/2002 | CA2019749C [.alpha.-(tert.butyl aminomethyl)-3,4-dichlorobenzyl] thioacetamide, a procedure for its preparation and its uses |
| 01/31/2002 | WO2002008181A1 Process for producing 2-hydroxy-4-methylthiobutanoic acid |
| 01/31/2002 | WO2002008180A1 Bis(4-mercaptophenyl) sulfide derivatives, process for the preparation thereof and electronic components |
| 01/31/2002 | WO2002008174A1 Phenylethylamine derivatives and their use in the treatment of melanoma |
| 01/31/2002 | US20020013499 Process for producing alpha-aminoketones |
| 01/31/2002 | US20020013476 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/31/2002 | US20020013374 Administering compound effective to inhibit binding of an amyloid beta peptide with alpha-7 nicotinic acetylcholine receptors |
| 01/31/2002 | US20020013370 Methods for identifying and treating resistant tumors |
| 01/31/2002 | US20020013311 Of the eye, nose, skin, ear, gastrointestinal tract, airways or lung and preventing or treating manifestations of systemic mastocytosis |
| 01/31/2002 | US20020011588 Liquid crystalline compounds |
| 01/31/2002 | DE10035651A1 New dialkyne compounds, used in liquid crystal media, especially in reflective, transflective and electrooptical displays, are cyclohexane compounds or heterocyclic analogues with lateral dialkyne substituent(s) |
| 01/30/2002 | EP1176186A2 Composition for mitigating coke formation in thermal cracking furnaces |
| 01/30/2002 | EP1176139A1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors |
| 01/30/2002 | EP1175395A1 Method of preparing n,n'-disubstituted-3,3'-dithiodipropionamide and method of preparing substituted 3-isothiazolone by using the same |